http://pr.gaeatimes.com Thu, 15 Dec 2011 05:00:00 +0000 http://wordpress.org/?v=2.7.1 en hourly 1 http://pr.gaeatimes.com/sword-ciboodle-enters-2012-with-rapid-global-expansion-54920/ http://pr.gaeatimes.com/sword-ciboodle-enters-2012-with-rapid-global-expansion-54920/#comments Thu, 15 Dec 2011 05:00:00 +0000 Sword Ciboodle http://pr.gaeatimes.com/sword-ciboodle-enters-2012-with-rapid-global-expansion-54920/ Original article on Gaea Times at  : Sword Ciboodle Enters 2012 with Rapid Global Expansion.]]> http://pr.gaeatimes.com/sword-ciboodle-enters-2012-with-rapid-global-expansion-54920/feed/ http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/ http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/#comments Mon, 12 Dec 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/ Source  : Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators.]]> http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/feed/ http://pr.gaeatimes.com/abbott-declares-352nd-consecutive-quarterly-dividend-54625/ http://pr.gaeatimes.com/abbott-declares-352nd-consecutive-quarterly-dividend-54625/#comments Fri, 09 Dec 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-declares-352nd-consecutive-quarterly-dividend-54625/ Read more : Abbott Declares 352nd Consecutive Quarterly Dividend.]]> http://pr.gaeatimes.com/abbott-declares-352nd-consecutive-quarterly-dividend-54625/feed/ http://pr.gaeatimes.com/abbott-initiates-clinical-trial-to-evaluate-the-absorb%e2%84%a2-bioresorbable-vascular-scaffold-compared-to-a-metallic-drug-eluting-stent-54568/ http://pr.gaeatimes.com/abbott-initiates-clinical-trial-to-evaluate-the-absorb%e2%84%a2-bioresorbable-vascular-scaffold-compared-to-a-metallic-drug-eluting-stent-54568/#comments Thu, 08 Dec 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-initiates-clinical-trial-to-evaluate-the-absorb%e2%84%a2-bioresorbable-vascular-scaffold-compared-to-a-metallic-drug-eluting-stent-54568/ Gaea News Network.]]> http://pr.gaeatimes.com/abbott-initiates-clinical-trial-to-evaluate-the-absorb%e2%84%a2-bioresorbable-vascular-scaffold-compared-to-a-metallic-drug-eluting-stent-54568/feed/ http://pr.gaeatimes.com/ubm-partners-with-the-abu-dhabi-centre-for-technical-and-vocational-education-and-training-to-produce-icampus-the-first-digital-university-in-middle-east-54184/ http://pr.gaeatimes.com/ubm-partners-with-the-abu-dhabi-centre-for-technical-and-vocational-education-and-training-to-produce-icampus-the-first-digital-university-in-middle-east-54184/#comments Thu, 01 Dec 2011 05:00:00 +0000 Ubm Studios Ubm Built Environment Client Solutions http://pr.gaeatimes.com/ubm-partners-with-the-abu-dhabi-centre-for-technical-and-vocational-education-and-training-to-produce-icampus-the-first-digital-university-in-middle-east-54184/ Read the original article: here.]]> http://pr.gaeatimes.com/ubm-partners-with-the-abu-dhabi-centre-for-technical-and-vocational-education-and-training-to-produce-icampus-the-first-digital-university-in-middle-east-54184/feed/ http://pr.gaeatimes.com/preval-signs-exclusive-distribution-agreement-for-sales-in-turkey-54028/ http://pr.gaeatimes.com/preval-signs-exclusive-distribution-agreement-for-sales-in-turkey-54028/#comments Tue, 29 Nov 2011 05:00:00 +0000 Preval http://pr.gaeatimes.com/preval-signs-exclusive-distribution-agreement-for-sales-in-turkey-54028/ Gaea News Network.]]> http://pr.gaeatimes.com/preval-signs-exclusive-distribution-agreement-for-sales-in-turkey-54028/feed/ http://pr.gaeatimes.com/abbott-expands-agreement-with-gsk-to-include-development-of-a-companion-diagnostic-test-for-an-additional-investigational-cancer-immunotherapy-antigen-53957/ http://pr.gaeatimes.com/abbott-expands-agreement-with-gsk-to-include-development-of-a-companion-diagnostic-test-for-an-additional-investigational-cancer-immunotherapy-antigen-53957/#comments Mon, 28 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-expands-agreement-with-gsk-to-include-development-of-a-companion-diagnostic-test-for-an-additional-investigational-cancer-immunotherapy-antigen-53957/ Read the original article  : Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen.]]> http://pr.gaeatimes.com/abbott-expands-agreement-with-gsk-to-include-development-of-a-companion-diagnostic-test-for-an-additional-investigational-cancer-immunotherapy-antigen-53957/feed/ http://pr.gaeatimes.com/new-data-reinforce-clinical-performance-of-abbotts-absorb-bioresorbable-vascular-scaffold-53348/ http://pr.gaeatimes.com/new-data-reinforce-clinical-performance-of-abbotts-absorb-bioresorbable-vascular-scaffold-53348/#comments Mon, 14 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/new-data-reinforce-clinical-performance-of-abbotts-absorb-bioresorbable-vascular-scaffold-53348/ New Data Reinforce Clinical Performance of Abbott’s ABSORB Bioresorbable Vascular Scaffold.]]> http://pr.gaeatimes.com/new-data-reinforce-clinical-performance-of-abbotts-absorb-bioresorbable-vascular-scaffold-53348/feed/ http://pr.gaeatimes.com/technomic-identifies-six-uk-foodservice-trends-for-2012-53202/ http://pr.gaeatimes.com/technomic-identifies-six-uk-foodservice-trends-for-2012-53202/#comments Thu, 10 Nov 2011 05:00:00 +0000 Technomic http://pr.gaeatimes.com/technomic-identifies-six-uk-foodservice-trends-for-2012-53202/ Source article on Gaea Times at  : Technomic Identifies Six U.K. Foodservice Trends for 2012.]]> http://pr.gaeatimes.com/technomic-identifies-six-uk-foodservice-trends-for-2012-53202/feed/ http://pr.gaeatimes.com/abbott-receives-ce-mark-for-new-hepatitis-test-53144/ http://pr.gaeatimes.com/abbott-receives-ce-mark-for-new-hepatitis-test-53144/#comments Wed, 09 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-receives-ce-mark-for-new-hepatitis-test-53144/ Source  : Abbott Receives CE Mark for New Hepatitis Test.]]> http://pr.gaeatimes.com/abbott-receives-ce-mark-for-new-hepatitis-test-53144/feed/ http://pr.gaeatimes.com/asia-next-generation-aircraft-drive-continued-airline-capacity-growth-53176/ http://pr.gaeatimes.com/asia-next-generation-aircraft-drive-continued-airline-capacity-growth-53176/#comments Wed, 09 Nov 2011 05:00:00 +0000 Ubm Aviation http://pr.gaeatimes.com/asia-next-generation-aircraft-drive-continued-airline-capacity-growth-53176/ Asia, Next-Generation Aircraft Drive Continued Airline Capacity Growth.]]> http://pr.gaeatimes.com/asia-next-generation-aircraft-drive-continued-airline-capacity-growth-53176/feed/ http://pr.gaeatimes.com/sword-ciboodle-teams-with-csc-to-advance-contact-center-operating-models-53073/ http://pr.gaeatimes.com/sword-ciboodle-teams-with-csc-to-advance-contact-center-operating-models-53073/#comments Tue, 08 Nov 2011 05:00:00 +0000 Sword Ciboodle http://pr.gaeatimes.com/sword-ciboodle-teams-with-csc-to-advance-contact-center-operating-models-53073/ Sword Ciboodle Teams with CSC to Advance Contact Center Operating Models.]]> http://pr.gaeatimes.com/sword-ciboodle-teams-with-csc-to-advance-contact-center-operating-models-53073/feed/ http://pr.gaeatimes.com/hahahsirva-announces-acquisition-of-peninsula-properties-hong-kong-52971/ http://pr.gaeatimes.com/hahahsirva-announces-acquisition-of-peninsula-properties-hong-kong-52971/#comments Mon, 07 Nov 2011 05:00:00 +0000 Sirva Inc. http://pr.gaeatimes.com/hahahsirva-announces-acquisition-of-peninsula-properties-hong-kong-52971/ Read the original article on Gaea Times at : hahahSIRVA Announces Acquisition of Peninsula Properties Hong Kong.]]> http://pr.gaeatimes.com/hahahsirva-announces-acquisition-of-peninsula-properties-hong-kong-52971/feed/ http://pr.gaeatimes.com/sirva-announces-acquisition-of-peninsula-properties-hong-kong-52980/ http://pr.gaeatimes.com/sirva-announces-acquisition-of-peninsula-properties-hong-kong-52980/#comments Mon, 07 Nov 2011 05:00:00 +0000 Sirva Inc. http://pr.gaeatimes.com/sirva-announces-acquisition-of-peninsula-properties-hong-kong-52980/ Source article on Gaea Times at  : SIRVA Announces Acquisition of Peninsula Properties Hong Kong.]]> http://pr.gaeatimes.com/sirva-announces-acquisition-of-peninsula-properties-hong-kong-52980/feed/ http://pr.gaeatimes.com/abbott-presents-humira%c2%ae-adalimumab-phase-3-study-results-for-patients-with-active-non-radiographic-axial-spondyloarthritis-52985/ http://pr.gaeatimes.com/abbott-presents-humira%c2%ae-adalimumab-phase-3-study-results-for-patients-with-active-non-radiographic-axial-spondyloarthritis-52985/#comments Mon, 07 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-presents-humira%c2%ae-adalimumab-phase-3-study-results-for-patients-with-active-non-radiographic-axial-spondyloarthritis-52985/ Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis.]]> http://pr.gaeatimes.com/abbott-presents-humira%c2%ae-adalimumab-phase-3-study-results-for-patients-with-active-non-radiographic-axial-spondyloarthritis-52985/feed/ http://pr.gaeatimes.com/abbott-announces-new-long-term-data-evaluating-use-of-humira%c2%ae-adalimumab-for-patients-with-long-standing-moderate-to-severe-rheumatoid-arthritis-and-for-patients-with-early-moderate-to-severe-r-52955/ http://pr.gaeatimes.com/abbott-announces-new-long-term-data-evaluating-use-of-humira%c2%ae-adalimumab-for-patients-with-long-standing-moderate-to-severe-rheumatoid-arthritis-and-for-patients-with-early-moderate-to-severe-r-52955/#comments Sun, 06 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-announces-new-long-term-data-evaluating-use-of-humira%c2%ae-adalimumab-for-patients-with-long-standing-moderate-to-severe-rheumatoid-arthritis-and-for-patients-with-early-moderate-to-severe-r-52955/ Source article  : Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA.]]> http://pr.gaeatimes.com/abbott-announces-new-long-term-data-evaluating-use-of-humira%c2%ae-adalimumab-for-patients-with-long-standing-moderate-to-severe-rheumatoid-arthritis-and-for-patients-with-early-moderate-to-severe-r-52955/feed/ http://pr.gaeatimes.com/abbott-to-present-new-data-for-key-vascular-products-at-tct-2011-52861/ http://pr.gaeatimes.com/abbott-to-present-new-data-for-key-vascular-products-at-tct-2011-52861/#comments Thu, 03 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-to-present-new-data-for-key-vascular-products-at-tct-2011-52861/ Original source on Gaea Times at : Abbott to Present New Data for Key Vascular Products at TCT 2011.]]> http://pr.gaeatimes.com/abbott-to-present-new-data-for-key-vascular-products-at-tct-2011-52861/feed/ http://pr.gaeatimes.com/abbott-to-present-broad-spectrum-of-compelling-data-for-humira%c2%ae-adalimumab-at-american-college-of-rheumatology-annual-scientific-meeting-52757/ http://pr.gaeatimes.com/abbott-to-present-broad-spectrum-of-compelling-data-for-humira%c2%ae-adalimumab-at-american-college-of-rheumatology-annual-scientific-meeting-52757/#comments Wed, 02 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-to-present-broad-spectrum-of-compelling-data-for-humira%c2%ae-adalimumab-at-american-college-of-rheumatology-annual-scientific-meeting-52757/ Source article on Gaea Times at  : Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting.]]> http://pr.gaeatimes.com/abbott-to-present-broad-spectrum-of-compelling-data-for-humira%c2%ae-adalimumab-at-american-college-of-rheumatology-annual-scientific-meeting-52757/feed/ http://pr.gaeatimes.com/cambium-networks-begins-operations-as-independent-organization-52781/ http://pr.gaeatimes.com/cambium-networks-begins-operations-as-independent-organization-52781/#comments Wed, 02 Nov 2011 05:00:00 +0000 Cambium Networks http://pr.gaeatimes.com/cambium-networks-begins-operations-as-independent-organization-52781/ Read this article on Gaea Times at : Cambium Networks Begins Operations as Independent Organization.]]> http://pr.gaeatimes.com/cambium-networks-begins-operations-as-independent-organization-52781/feed/ http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/ http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/#comments Tue, 01 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/ Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent.]]> http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/feed/ http://pr.gaeatimes.com/sword-ciboodle-leverages-sas%c2%ae-analytics-in-new-intelligent-contact-center-52376/ http://pr.gaeatimes.com/sword-ciboodle-leverages-sas%c2%ae-analytics-in-new-intelligent-contact-center-52376/#comments Tue, 25 Oct 2011 05:00:00 +0000 Sword Ciboodle http://pr.gaeatimes.com/sword-ciboodle-leverages-sas%c2%ae-analytics-in-new-intelligent-contact-center-52376/ Gaea News Network.]]> http://pr.gaeatimes.com/sword-ciboodle-leverages-sas%c2%ae-analytics-in-new-intelligent-contact-center-52376/feed/ http://pr.gaeatimes.com/abbott-reports-strong-ongoing-third-quarter-results-confirms-double-digit-ongoing-earnings-growth-outlook-for-2011-52100/ http://pr.gaeatimes.com/abbott-reports-strong-ongoing-third-quarter-results-confirms-double-digit-ongoing-earnings-growth-outlook-for-2011-52100/#comments Wed, 19 Oct 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-reports-strong-ongoing-third-quarter-results-confirms-double-digit-ongoing-earnings-growth-outlook-for-2011-52100/ Abbott Reports Strong Ongoing Third Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2011.]]> http://pr.gaeatimes.com/abbott-reports-strong-ongoing-third-quarter-results-confirms-double-digit-ongoing-earnings-growth-outlook-for-2011-52100/feed/ http://pr.gaeatimes.com/abbott-to-separate-into-two-leading-companies-in-diversified-medical-products-and-research-based-pharmaceuticals-52109/ http://pr.gaeatimes.com/abbott-to-separate-into-two-leading-companies-in-diversified-medical-products-and-research-based-pharmaceuticals-52109/#comments Wed, 19 Oct 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-to-separate-into-two-leading-companies-in-diversified-medical-products-and-research-based-pharmaceuticals-52109/ Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals.]]> http://pr.gaeatimes.com/abbott-to-separate-into-two-leading-companies-in-diversified-medical-products-and-research-based-pharmaceuticals-52109/feed/ http://pr.gaeatimes.com/abbotts-absorb%e2%84%a2-bioresorbable-vascular-scaffold-honored-with-wall-street-journal-technology-innovation-award-51963/ http://pr.gaeatimes.com/abbotts-absorb%e2%84%a2-bioresorbable-vascular-scaffold-honored-with-wall-street-journal-technology-innovation-award-51963/#comments Mon, 17 Oct 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbotts-absorb%e2%84%a2-bioresorbable-vascular-scaffold-honored-with-wall-street-journal-technology-innovation-award-51963/ Source article  : Abbott’s ABSORB™ Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award.]]> http://pr.gaeatimes.com/abbotts-absorb%e2%84%a2-bioresorbable-vascular-scaffold-honored-with-wall-street-journal-technology-innovation-award-51963/feed/ http://pr.gaeatimes.com/statement-from-nalini-m-rajamannan-md-on-her-termination-from-northwestern-university-chicago-il-on-being-a-whistleblower-for-exposing-human-experimentation-of-investigational-fda-devices-51869/ http://pr.gaeatimes.com/statement-from-nalini-m-rajamannan-md-on-her-termination-from-northwestern-university-chicago-il-on-being-a-whistleblower-for-exposing-human-experimentation-of-investigational-fda-devices-51869/#comments Thu, 13 Oct 2011 05:00:00 +0000 Nalini Rajamannan Md http://pr.gaeatimes.com/statement-from-nalini-m-rajamannan-md-on-her-termination-from-northwestern-university-chicago-il-on-being-a-whistleblower-for-exposing-human-experimentation-of-investigational-fda-devices-51869/ Statement From Nalini M. Rajamannan, MD on Her Termination From Northwestern University, Chicago, IL on Being a Whistleblower for Exposing Human Experimentation of Investigational FDA Devices.]]> http://pr.gaeatimes.com/statement-from-nalini-m-rajamannan-md-on-her-termination-from-northwestern-university-chicago-il-on-being-a-whistleblower-for-exposing-human-experimentation-of-investigational-fda-devices-51869/feed/ http://pr.gaeatimes.com/calamos-releases-quarterly-economic-review-and-outlook-q3-2011-51788/ http://pr.gaeatimes.com/calamos-releases-quarterly-economic-review-and-outlook-q3-2011-51788/#comments Wed, 12 Oct 2011 05:00:00 +0000 Calamos Advisors Llc http://pr.gaeatimes.com/calamos-releases-quarterly-economic-review-and-outlook-q3-2011-51788/ Calamos Releases Quarterly Economic Review and Outlook - Q3, 2011.]]> http://pr.gaeatimes.com/calamos-releases-quarterly-economic-review-and-outlook-q3-2011-51788/feed/ http://pr.gaeatimes.com/anixter-international-significantly-expands-presence-in-the-kingdom-of-saudi-arabia-through-the-creation-of-anixter-saudi-arabia-limited-51518/ http://pr.gaeatimes.com/anixter-international-significantly-expands-presence-in-the-kingdom-of-saudi-arabia-through-the-creation-of-anixter-saudi-arabia-limited-51518/#comments Thu, 06 Oct 2011 05:00:00 +0000 Anixter International Inc. http://pr.gaeatimes.com/anixter-international-significantly-expands-presence-in-the-kingdom-of-saudi-arabia-through-the-creation-of-anixter-saudi-arabia-limited-51518/ Read the original article: here.]]> http://pr.gaeatimes.com/anixter-international-significantly-expands-presence-in-the-kingdom-of-saudi-arabia-through-the-creation-of-anixter-saudi-arabia-limited-51518/feed/ http://pr.gaeatimes.com/abbott-enrolls-first-us-patient-in-global-excel-trial-comparing-xience-to-coronary-artery-bypass-surgery-51350/ http://pr.gaeatimes.com/abbott-enrolls-first-us-patient-in-global-excel-trial-comparing-xience-to-coronary-artery-bypass-surgery-51350/#comments Tue, 04 Oct 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-enrolls-first-us-patient-in-global-excel-trial-comparing-xience-to-coronary-artery-bypass-surgery-51350/ Read more : Abbott Enrolls First U.S. Patient in Global EXCEL Trial Comparing XIENCE to Coronary Artery Bypass Surgery.]]> http://pr.gaeatimes.com/abbott-enrolls-first-us-patient-in-global-excel-trial-comparing-xience-to-coronary-artery-bypass-surgery-51350/feed/ http://pr.gaeatimes.com/caterpillar-and-dealer-ring-power-sign-agreement-with-apr-energy-51092/ http://pr.gaeatimes.com/caterpillar-and-dealer-ring-power-sign-agreement-with-apr-energy-51092/#comments Thu, 29 Sep 2011 05:00:00 +0000 Caterpillar Inc. http://pr.gaeatimes.com/caterpillar-and-dealer-ring-power-sign-agreement-with-apr-energy-51092/ here.]]> http://pr.gaeatimes.com/caterpillar-and-dealer-ring-power-sign-agreement-with-apr-energy-51092/feed/ http://pr.gaeatimes.com/chiltern-expands-north-american-operations-with-a-new-office-in-illinois-51156/ http://pr.gaeatimes.com/chiltern-expands-north-american-operations-with-a-new-office-in-illinois-51156/#comments Thu, 29 Sep 2011 05:00:00 +0000 Chiltern http://pr.gaeatimes.com/chiltern-expands-north-american-operations-with-a-new-office-in-illinois-51156/ Source article  : Chiltern Expands North American Operations With a New Office in Illinois.]]> http://pr.gaeatimes.com/chiltern-expands-north-american-operations-with-a-new-office-in-illinois-51156/feed/